Locations:

Tag: daratumumab

November 17, 2021/Cancer/Research

Adding Daratumumab to Treatment Regimen May Improve Outcomes in Patients With Immunoglobulin Light-Chain Amyloidosis

Study associates human CD38-targeting antibody with fewer complications

May 6, 2020/Cancer/Research

Research Shows Daratumumab’s Effectiveness in AL Amyloidosis

Study finds good hematologic response and rapid action

BackPage 1 of 1Next

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy